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Abstract The clinical relevance of fungal infections has
increased dramatically in recent decades as a consequence
of the rise of immunocompromised populations, and efforts
to understand the underlying mechanisms of protective
immunity have attracted renewed interest. Here we review
Dectin-1, a pattern recognition receptor involved in anti-
fungal immunity, and discuss recent discoveries of poly-
morphisms in the gene encoding this receptor which result
in human disease.
Introduction
The immune system of mammals and other vertebrates is
characterized by two interrelated components, the innate
and adaptive responses, both of which are required for the
resolution of most infections. The innate immune system
comprises cells such as macrophages, neutrophils, and
dendritic cells, which are broadly distributed throughout
the body, including at portals of pathogen entry, and are
involved in the initial capture and presentation of microbial
antigens. The ﬁeld of innate immunology was revolution-
ized by Charlie Janeway Jr. with the theory of pattern
recognition, which proposed that conserved structures of
infectious organisms (the pathogen associated molecular
patterns or PAMPs) were recognized by the immune sys-
tem through a set of specialized germline-encoded recep-
tors (the pattern recognition receptors or PRRs). Janeway’s
theory not only suggested a general principle of innate
immune recognition, it also provided a foundation for the
current understanding of how it connects with the adaptive
immune system (Medzhitov 2009). Accordingly, the ﬁeld
of immunology has witnessed the discovery of many dif-
ferent PRRs over the last few years, some of which can
induce cellular responses and initiate the adaptive arm of
the immune system. The adaptive response involves spe-
ciﬁc recognition of microbial antigens by lymphocyte
receptors resulting in clonal expansion, cellular differenti-
ation, the production of speciﬁc antibodies, and the
development of immunological memory. Here we review
recent insights regarding the innate recognition and
response to fungal infections. We focus in particular on
Dectin-1, a PRR that we and others have shown is
important in antifungal defense in humans and mice.
However, although beyond the scope of this review, the
reader is reminded that there are also several polymor-
phisms in other genes (such as MBL and STAT3, for
example) that have been linked with susceptibility to fun-
gal infections (for reviews see Antachopoulos et al. 2007;
Carvalho et al. 2010).
Pattern recognition receptors in cellular responses
against fungal infections
PRRs can be broadly categorized based on their cellular
expression—on the cell surface, in intracellular compart-
ments, or secreted into the serum or tissue ﬂuids; these
groups can be further subdivided into families based on
structure and function. PRRs account for the quick
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a PAMP, the PRR-expressing effector cells function
immediately rather than after they have undergone somatic
recombination and proliferation, as occurs in adaptive
immunity. PRRs activate effector cells by driving key
cellular functions, and the most important and widely
studied PRRs in terms of fungal recognition are Toll-like
receptors (TLRs) and C-type lectin receptors (CLRs).
Toll-like receptors
The TLR proteins are characterized by extracellular leu-
cine-rich repeat motifs that are involved in ligand recog-
nition. They also possess a cytoplasmic Toll/interleukin
(IL-1) receptor (TIR) domain, which mediates intracellular
signaling. Toll was ﬁrst discovered in Drosophila mela-
nogaster as a cell surface receptor involved in the regula-
tion of development and subsequently shown to function in
immunity (Hashimoto et al. 1988; Lemaitre et al. 1996). To
date, 10 and 12 TLRs have been identiﬁed in humans and
mice, respectively. Most TLRs have now been demon-
strated as having PAMP ‘‘ligands,’’ including lipoproteins,
lipids, proteins, and nucleic acids derived from a wide
variety of microorganisms (Akira et al. 2006). Ligand
recognition by TLR homo- or heterodimers leads to the
recruitment of intracellular adaptors such as MyD88, Mal
(also called TIRAP), TRIF, and TRAM. This activates
signaling cascades that ultimately trigger transcription
factors and induce TLR-speciﬁc patterns of gene expres-
sion and the production of various cytokines and
chemokines.
A role for TLRs in antifungal defense was ﬁrst suggested
by the increased susceptibility of Toll-deﬁcient Drosophila
to infection with Aspergillus fumigatus (Lemaitre et al.
1996). It has since been shown that mice lacking the TLR
adaptor MyD88 are highly susceptible to fungal infections,
including Candida albicans, Aspergillus fumigatus, and
Cryptococcus neoformans (Netea et al. 2006). The precise
fungal ligands detected by TLRs are not very well charac-
terized; however, it is known that phospholipomannans are
recognized by TLR2 and glucuronoxylomannans and
mannans are recognized by TLR4 (Netea et al. 2008).
It transpires that the involvement of individual TLRs in
antifungal immunity is not as clear-cut as with the MyD88
adaptor,asconﬂictingresultshavebeenreportedbydifferent
research groups. For example, initial studies suggested that
TLR4-deﬁcient mice were more susceptible to disseminated
candidiasis. Other studies using models of intragastric
infection or intravenous reinfection also showed that
TLR4
-/- mice were more susceptible to C. albicans
(Bellocchio et al. 2004). In contrast, TLR4
-/- mice were
equally susceptible as wild-type mice in models of intrave-
nousinfectionwith C.albicansyeast(Murcianoetal.2006),
andevensurvivedlongerinamodelofintravenousinfection
with C. albicans hyphae (Bellocchio et al. 2004). A recent
investigationthatusedapanelofdifferentC.albicansstrains
suggests that TLR4 is important for the recognitionof some,
but not all, strains of C.albicans (Netea et al. 2010), and this
variability in recognition is likely to account for the differ-
ences observed in the above studies. TLR2, TLR9, TLR1,
and TLR6 have also been implicated in the recognition and
response to fungal pathogens (Carvalho et al. 2010; van de
Veerdonk et al. 2008). Although the precise contributions of
individual TLRs is still unclear, an integrated model of
fungal recognition involving TLRs and C-type lectins has
been proposed and highlights the complex interaction
that occurs between host PRRs and invading pathogens
(Netea et al. 2008).
There are associations between genetic variations in
TLRs and fungal diseases in humans (for review see
Carvalho et al. 2010). For example, polymorphisms in
TLR4 have been associated with susceptibility to invasive
aspergillosis in certain transplant recipients and chronic
cavitary pulmonary aspergillosis. Furthermore, TLR4
polymorphisms were shown to contribute to a higher risk
of systemic Candida infection. An association between a
TLR9 polymorphism and the development of allergic
bronchopulmonary aspergillosis has also been reported. A
global role of TLRs in host defense against fungal infec-
tions in humans, however, has been questioned by clinical
observations that patients with a defect in MyD88 are not
any more susceptible to fungal infections than the normal
population (von Bernuth et al. 2008).
C-type lectin receptors
A noteworthy discovery in the ﬁeld of innate immunology
wastheidentiﬁcationofC-typelectinreceptors(CLRs)with
the ability to induce intracellular signaling. These receptors
have been divided into 17 groups, but of relevance here are
the myeloid-expressed CLRs belonging to the Group II, V,
andVIsubgroups(ZelenskyandGready2005).Anumberof
these receptors, namely, DC-SIGN, the mannose receptor,
Dectin-1,and Dectin-2,functioninthe recognition offungal
pathogensandhavebeenreviewedelsewhere(Willmentand
Brown 2008). Of these receptors, Dectin-1 is the most
extensively studied interms ofa role infungaldisease and is
the focus of the remainder of this review.
Dectin-1
Structure and expression
Dectin-1 consists of a single extracellular C-type lectin-like
domain (CTLD), a transmembrane region, and a
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123cytoplasmic tail that contains a single tyrosine-based acti-
vation motif (Fig. 1). In both humans and mice, alternative
splicing generates two major Dectin-1 isoforms and a
number of minor isoforms (Heinsbroek et al. 2006; Will-
ment et al. 2001). The two major isoforms, which are the
only isoforms functional for b-glucan binding, differ with
regard to the presence or absence of a stalk region and their
ability to bind and induce cellular responses (Heinsbroek
et al. 2006).
Originally thought to be a dendritic cell-speciﬁc recep-
tor, Dectin-1 is now known to be expressed by many other
cell types such as monocytes, macrophages, neutrophils,
and a subset of T cells (Taylor et al. 2002). Dectin-1 (bGR)
is also expressed on B cells, eosinophils, and mast cells in
humans, and recent reports have also demonstrated
expression of this receptor on murine microglia (Olynych
et al. 2006; Shah et al. 2008; Willment et al. 2005).
Whether the differences in expression between species are
functionally signiﬁcant is currently unclear. Consistent
with a potential role in immune surveillance, this receptor
is prominently expressed at portals of pathogen entry such
as the lung and intestine (Reid et al. 2004; Taylor et al.
2002). The levels of Dectin-1 expression can be signiﬁ-
cantly inﬂuenced by various factors such as steroids, some
cytokines, and microbial stimuli. For example, IL-4, IL-13,
and GM-CSF (granulocyte–macrophage colony-stimulat-
ing factor) cause signiﬁcant upregulation of Dectin-1
expression. On the other hand, IL-10, LPS, and dexa-
methasone trigger downregulation of Dectin-1 expression
(Willment et al. 2003). In addition, the systemic adminis-
tration of C. albicans resulted in an increase in Dectin-1
expression on leukocytes. In contrast, Dectin-1 expression
was decreased during polymicrobial sepsis (Ozment-
Skelton et al. 2009).
Dectin-1 mediated fungal b-glucan recognition
A number of endogenous and exogenous ligands have been
reported for Dectin-1, but this receptor is best known for its
ability to recognize fungal b-glucans. b-Glucans are car-
bohydrate PAMPs found predominantly in fungal cell
walls, but they are also present in plants and some bacteria.
The b-glucan components of fungal cell walls consist
primarily of (1?3)-b-D-linked polymer backbones with
(1?6)-b-linked side chains of varying length and distri-
bution (Romani et al. 2004; Tsoni and Brown 2008). These
carbohydrates are well known for their anti-infective and
antitumorogenic activities, and the identiﬁcation of Dectin-
1 as a PRR that recognizes b-glucans has enabled signiﬁ-
cant advances in our understanding of the mechanisms
underlying these activities. A number of other receptors
have also been implicated in b-glucan recognition, namely,
complement receptor 3 (CR3), lactosylceramide, langerin,
and the scavenger receptors CD5, CL-P1, SCARF1, and
CD36 (de Jong et al. 2010; Jang et al. 2009; Means et al.
2009; Ross et al. 1987; Vera et al. 2009; Zimmerman et al.
1998). We and others have shown that Dectin-1 is the
primary receptor for b-glucans, at least on leukocytes.
However, it should be noted that the other receptors may
have signiﬁcant roles in mediating responses to b-glucans,
particularly in nonimmune cells.
Initially identiﬁed as a receptor that recognized an
unidentiﬁed ligand on T lymphocytes (Ariizumi et al.
2000), Dectin-1 was reidentiﬁed as a receptor for b-glucans
following a screen of a murine macrophage cDNA
expression library with zymosan, a b-glucan-rich extract of
S. cerevisiae (Brown and Gordon 2001). Biochemical
characterization of the interaction has shown that Dectin-1
is highly speciﬁc for (1?3)-linked b-glucans and that its
Fig. 1 A schematic
representation of the structure of
Dectin-1
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123binding afﬁnity for these carbohydrates is inﬂuenced by
factors such as polymer length and number of branches
(Adams et al. 2008; Goodridge et al. 2009b; Palma et al.
2006). The manner in which Dectin-1 recognizes b-glucans
is still unclear as its CTLD lacks the residues typically
known for carbohydrate binding and ligand recognition is
metal ion-independent. However, at least two residues
ﬂanking a shallow groove on the protein surface, Trp
221
and His
223, have been implicated for b-glucan binding
(Adachi et al. 2004).
Dectin-1 has been shown to interact with a number of
fungal species, including Candida, Pneumocystis, Saccha-
romyces, Aspergillus, Coccidioides, and Penicillum,b y
way of its b-glucan speciﬁcity (Brown et al. 2003; Gantner
et al. 2005; Gersuk et al. 2006; Nakamura et al. 2008; Saijo
et al. 2007; Steele et al. 2003, 2005; Taylor et al. 2007;
Viriyakosol et al. 2005). It has also been shown that
Dectin-1 can recognize other nonfungal pathogens. For
instance, a role for this receptor has been suggested in the
recognition of mycobacteria (Lee et al. 2009; Rothfuchs
et al. 2007; Shin et al. 2008; Yadav and Schorey 2006),
which do not possess b-glucans, suggesting that there may
still be unidentiﬁed exogenous ligands of Dectin-1 yet to be
discovered.
Cellular responses induced by Dectin-1 following
fungal b-glucan recognition
Dectin-1 recognition of b-glucans can result in the induc-
tion of a number of cellular responses, including ligand
uptake by phagocytosis and endocytosis, dendritic cell
maturation, the respiratory burst, the production of ara-
chidonic acid metabolites, and the induction of numerous
cytokines, including tumor necrosis factor (TNF), IL-10,
IL-2, IL-23, and IL-6, as well as chemokines like CXCL2
(Brown 2006; Reid et al. 2009). In addition to triggering
innate immune responses, ligation of Dectin-1 can also
activate adaptive immune responses. For example, Dectin-
1-mediated activation of dendritic cells in response to
curdlan, a selective agonist of this receptor, has been
shown to direct the differentiation of T-helper 17 (Th17)
and T-helper 1 (Th1) CD4
? T cells in vitro (LeibundGut-
Landmann et al. 2007). Furthermore, curdlan acted as an
adjuvant for the priming of Th17 and Th1 CD4
? T cells in
vivo (LeibundGut-Landmann et al. 2007). Dectin-1 has
also been implicated in the expansion and function of
regulatory T cells (Tregs) (Dillon et al. 2006; Karumuthil-
Melethil et al. 2008), as well as in the conversion of
selected populations of Tregs into IL-17, producing T cells
that cannot be strictly classiﬁed as either Th17 cells or
Tregs (Osorio et al. 2008). In addition, Dectin-1 signaling
can induce CD8
? T-cells responses, as demonstrated by in
vivo studies that showed that curdlan was found to
efﬁciently prime cytotoxic T-cell responses (Leibundgut-
Landmann et al. 2008). Signaling induced via Dectin-1
alone can directly trigger some of these responses; how-
ever, other responses such as the production of proin-
ﬂammatory cytokines require, or are enhanced by,
collaborative signaling with TLRs (Brown et al. 2003;
Dennehy et al. 2008; Gantner et al. 2003). Yet another
element that adds to the complexity of Dectin-1 signaling
was revealed by studies showing that the ability of b-glu-
cans to directly trigger these responses is cell-type depen-
dent (Goodridge et al. 2009a; Rosas et al. 2008). In the
following section we review the current understanding of
the Dectin-1-mediated signaling pathways that underlie
some of these responses.
Dectin-1 intracellular signaling
Dectin-1 signaling is mediated by a sequence within the
cytoplasmic tail that resembles an immunoreceptor tyro-
sine-based activation motif (ITAM). Traditional ITAMs
present in T-cell receptors, B-cell receptors, and Fc
receptors contain an amino acid sequence comprising
duplicate YXXL/I motifs (YXXL/IX6-12YXXL/I), where Y
is tyrosine, L is leucine, I is isoleucine, and X denotes any
amino acid. Phosphorylation of both tyrosines by Src
family kinases is required for recruitment of Syk family
kinases and subsequent downstream signaling (Underhill
and Goodridge 2007). The cytoplasmic tail of Dectin-1 also
contains two tyrosines: the membrane-proximal tyrosine is
located in a YXXL motif and the membrane-distal one is
found in a motif containing an additional amino acid
(YxxxL and YxxxI in humans and mice, respectively)
(Brown 2006). Dectin-1 also becomes tyrosine phosphor-
ylated following ligand binding, but in contrast to tradi-
tional ITAM receptors, phosphorylation of only the
membrane-proximal tyrosine is required for Dectin-1
signaling (Fuller et al. 2007; Rogers et al. 2005). This
single-tyrosine-based motif (YxxL) is now known as an
ITAM-like motif or a hemITAM. Dectin-1 was the ﬁrst
receptor shown to signal via this pathway, which although
quite similar to ITAM signaling, is unique in its depen-
dence on only a single tyrosine. Other receptors, speciﬁ-
cally the C-type lectins CLEC-2 and CLEC-9A, have
subsequently been shown to also signal via an ITAM-like
motif (Fuller et al. 2007; Huysamen et al. 2008). Although
the exact nature of the interaction between Syk and Dectin-
1 is unclear, a model suggesting that Syk bridges two
monophosphorylated molecules has been proposed (Brown
2006; Fuller et al. 2007; Goodridge et al. 2009b; Rogers
et al. 2005). Indeed, experimental evidence strongly sug-
gests that the related ITAM-like-containing receptor
CLEC-2 regulates Syk through dimerization, with each of
the Syk SH2 domains binding to a phosphorylated YxxL
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123sequence in the individual cytosolic tails of two CLEC-2
proteins (Hughes et al. 2010).
Ligand binding and the subsequent recruitment of Syk
to Dectin-1 result in activation of PLCc2, leading to the
engagement of the caspase recruitment domain (CARD)-
containing protein CARD9 (Gross et al. 2006; Tassi et al.
2009; Xu et al. 2009). CARD9, which then assembles
with BCL10 and MALT1, has been identiﬁed as a key
downstream adaptor required to link Dectin-1/Syk ligation
to canonical NF-jB activation (Gross et al. 2006; Hara
et al. 2007) (Fig. 2). Work by Gringhuis et al. (2009) also
demonstrated Dectin-1 as the ﬁrst PRR to induce nonca-
nonical NF-jB activation. In addition, these authors
showed that the stimulation of Dectin-1 with curdlan or
C. albicans induced a second Syk-independent signaling
pathway mediated by the serine-threonine kinase Raf-1.
This pathway integrates with the Syk pathway at the point
of NF-KB activation and might be involved in the path-
ogenesis of fungal infections (Gringhuis et al. 2009).
Dectin-1 has also been shown to trigger NFAT activation,
which regulates the induction of early growth response
(Egr) family transcription factors Egr-2 and Egr-3
(Goodridge et al. 2007). Evidence also exists for Syk-
dependent pathways that do not rely on CARD9 for
cytokine production, e.g., activation of the MAP kinase
ERK (Slack et al. 2007).
Dectin-1 in defense against fungal pathogens and effects
of genetic polymorphisms/deﬁciency in mice
and humans
Over the last few decades the growth of immunocompro-
mised populations, such as individuals infected with HIV
and transplant recipients, has resulted in an increased
clinical relevance of fungal diseases. Thus, fungal research
has attracted renewed interest, particularly efforts that seek
to understand the mechanisms underlying protective
immunity. In this section we discuss the role of Dectin-1 in
antifungal immunity and highlight studies that demonstrate
the consequences of Dectin-1 deﬁciency in fungal
infections.
As mentioned previously, the recognition of fungal
b-glucans by Dectin-1 results in a variety of cellular
responses, some of which are host protective such as fungal
uptake and killing, and the production of inﬂammatory
cytokines and chemokines. Interestingly, Dectin-1 also
induces the production of IL-10, an anti-inﬂammatory
cytokine whose role during fungal infection is unclear. The
presence of IL-10 has traditionally been thought of as dis-
advantageous to the host during fungal infection; however,
recent investigations have led to the proposal that the
inhibitory action of IL-10 on leukocyte activation may
be important for limiting host damage during severe
Fig. 2 Signaling pathway
induced by Dectin-1. Upon
ligand binding, Dectin-1
becomes tyrosine-
phosphorylated by Src kinases,
thereby providing a docking site
for Syk which initiates
downstream signaling. The
downstream signaling is
effected by molecules such as
CARD9, Bcl10, and MALT1,
which lead to NF-jB activation
and cytokine production.
Dectin-1 can also activate
NFAT and noncanonical NF-jB
in a CARD9-Bcl10-MALT1-
independent manner.
Stimulation of Dectin-1 with
b-glucans can also induce a
second Syk-independent
signaling pathway mediated by
the serine-threonine kinase
Raf-1
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123inﬂammation (Romani and Puccetti 2006). It has also been
shown that IL-10 is involved in the development of Tregs,
whose modulatory actions are beneﬁcial in mucosal and
cutaneousinfectionsandwhichareknowntobeessentialfor
the induction of long-term immunity to C. albicans (Netea
etal.2004).Incontrast,ithasbeenproposedthatinsituations
such as disseminated candidiasis, where the pathogen pen-
etrates the mucosa and disseminates through the blood-
stream, the presence of Tregs is detrimental to the host
(Netea et al. 2004).
We have also mentioned that Dectin-1 can drive other
aspects of adaptive immunity, including Th1, Th17, and
CTL responses, although there have been no studies looking
speciﬁcally at the roles of these Dectin-1-mediated
responses in antifungal immunity. Nevertheless, it is gen-
erallyacceptedthataTh1responseisrequiredforprotection
against fungal infection in healthy hosts (Romani 2004). On
the other hand, whether a Th17 response is required for
efﬁcient antifungal immunity is a more contentious issue,
with contradictory reports demonstrating Th17 cells as both
beneﬁcial and detrimental to the host during systemic
infections with Candida (Bozza et al. 2008; Huang et al.
2004; Romani 2004; Saijo et al. 2010; Zelante et al. 2007).
In contrast, Th17 cells are known to be important during
mucosal infections with Candida (Conti et al. 2009). The
speciﬁc role of CTLs in direct antifungal responses is also
undeﬁned;however,ithasbeenshownthatCD8
?Tcellsare
activated during fungal infections and can play a protective
role in some cases (Leigh et al. 2006; Lindell et al. 2005;
Marquis et al. 2006; Wuthrich et al. 2003).
Interestingly, Dectin-2, another Syk/CARD9-coupled
CLR, has also been shown to mediate dendritic cell acti-
vation and induction of Th17 immunity in response to
C. albicans (Robinson et al. 2009). Furthermore, in the
ﬁnal stages of writing this review, an investigation using
Dectin-2-deﬁcient mice reported that this receptor was
important in host defense against systemic C. albicans in
mice (Saijo et al. 2010).
It is important to note that fungal morphology is a major
determinant in the detection of cell wall b-glucans, as the
exposure of these carbohydrates can vary from one fungal
morphotype to another. For example, it has been shown
that Dectin-1 recognizes C. albicans yeast but not ﬁla-
mentous forms (Gantner et al. 2005). Thus, the ability of
C. albicans to switch between different forms may be a key
virulence strategy to evade host immune responses (Cald-
erone and Fonzi 2001; Lo et al. 1997; Saville et al. 2003).
In fact, C. albicans mutants that lack the ability to switch
from yeast to ﬁlamentous forms have been reported to be
avirulent in mouse models (Lo et al. 1997). In A. fumigatus,
swollen conidia and early germlings displaying surface
b-glucans are recognized by Dectin-1, hyphal forms are
recognized to a lesser degree, and resting conidia are not
recognized (Gersuk et al. 2006; Hohl et al. 2005; Steele
et al. 2005; Torosantucci et al. 2005). It has also been
suggested that fungal pathogens actively mask their
b-glucans to avoid immune recognition by Dectin-1
(Gantner et al. 2005; Wheeler and Fink 2006), prompting
investigations into drugs, such as caspofungin, which
enhance the exposure of b-glucans and improve antifungal
responses (Hohl et al. 2008; Lamaris et al. 2008; Wheeler
and Fink 2006; Wheeler et al. 2008).
Increasing evidence from in vivo studies, although not
entirely consistent, suggests an important role for Dectin-1
in antifungal immunity. Studies in our laboratory have
shown that the deletion of Clec7a, the gene encoding
Dectin-1, signiﬁcantly increased susceptibility of mice to
systemic infection with C. albicans (Taylor et al. 2007).
Loss of Dectin-1 in this model resulted in increased fungal
burdens and much lower survival times. A peritoneal
infection model revealed that the Dectin-1 knockout mice
had fewer recruited cells than wild types, including neu-
trophils and inﬂammatory monocytes, which correlated
with defects in the production of cytokines and chemokines
such as TNF, IL-6, CCL2, CCL3, and GM-CSF. This study
suggested a fundamental role of b-glucan recognition by
Dectin-1 in antifungal immunity and the requirement for
Dectin-1-dependent signaling for the induction of protec-
tive immune responses (Taylor et al. 2007). In contrast to
this study, Saijo et al. showed that Dectin-1-deﬁcient mice
were not more susceptible than wild-type mice to infection
with C. albicans (Saijo et al. 2007). We suspect that the
inconsistencies between these two studies arose as a result
of the use of different fungal strains.
Nevertheless, other studies have supported a role for
Dectin-1 in antifungal immunity. In a model of oral
candidiasis, Dectin-1-deﬁcient mice showed increased
susceptibility, with enhanced dissemination and decreased
survival times (Hise et al. 2009). Furthermore, mice
deﬁcient in the downstream signaling component CARD9
were similarly more susceptible to systemic C. albicans
infection (Gross et al. 2006). Dectin-1 is also required
during infection with other fungal pathogens; e.g., Dec-
tin-1-deﬁcient mice displayed increased susceptibility to
A. fumigatus infection which correlated with impaired
cytokine production and fungal killing (Steele et al. 2005;
Werner et al. 2009). Furthermore, in a model of intra-
nasal infection with Pneumocystis carinii, Dectin-1-deﬁ-
cient mice were found to be more susceptible than
wild-type mice in the early stages of infection (Saijo
et al. 2007).
Recently, an investigation by Ferwerda et al. provided
deﬁnitive evidence of the role of Dectin-1 during fungal
infections in humans. This study identiﬁed and described a
polymorphism of human Dectin-1 in four members of a
Dutch family who were affected by either recurrent
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123vulvovaginal candidiasis or onychomycosis (fungal infec-
tion of the nail), or both (Ferwerda et al. 2009). The
polymorphism was characterized by an early-stop-codon
mutation (Y238X) in the CTLD of Dectin-1, resulting in
defective expression and lack of b-glucan recognition by
phagocytes. In addition, the mutation resulted in impaired
production of cytokines, including IL-17. However, the
uptake and killing of C. albicans by neutrophils was not
affected. This suggests that alternative receptor pathways
can mediate these activities in the absence of Dectin-1, and
this is likely to provide protection against systemic fungal
infection in these individuals (Ferwerda et al. 2009).
This study also indicated that there are gene-dose
effects associated with the Y238X mutation. For example,
the homozygous daughters were 10-12 years of age at
onset of symptoms, but the heterozygous mother and
father were 40 and 55 years of age, respectively. Fur-
thermore, heterozygotes had an intermediate production
of proinﬂammatory cytokines upon stimulation with
C. albicans or b-glucan and were statistically signiﬁcantly
more often colonized with C. albicans than patients with
wild-type Dectin-1 (Plantinga et al. 2009). In terms of the
frequency of the mutation, analysis indicated its presence
only in populations from Africa and western Eurasia
(allele frequency of 3-7%), with the highest prevalence
(nearly 40%) found in the San population in South Africa
(Ferwerda et al. 2009).
Plantinga et al. also investigated the association of the
Dectin-1 polymorphism with C. albicans colonization in
patients undergoing hematopoietic stem cell transplanta-
tion (HSCT) (Plantinga et al. 2009). Treatment of patients
who have hematological malignancies with HSCT is
accompanied by a high incidence of invasive fungal
infections which cause considerable morbidity and mor-
tality (Barnes and Marr 2007). The study by Plantinga et al.
demonstrated that the Y238X Dectin-1 polymorphism is
associated with increased susceptibility to oral and gas-
trointestinal colonization with Candida species in HSCT
recipients (Plantinga et al. 2009). These ﬁndings afﬁrm the
importance of Dectin-1 in protection against fungal infec-
tions in immunocompromised patients, including those
undergoing transplantation. The authors propose the
implementation of an approach in which patients with the
polymorphism are considered for antifungal prophylaxis to
help prevent systemic candidiasis.
A further study investigated whether the Dectin-1 early-
stop-codon polymorphism could have an impact on the
immunological response following transplantation (van der
Velden et al. 2010). The authors speciﬁcally screened for
association between the Dectin-1 polymorphism and the
incidence of graft-versus-host disease (GvHD) following
stem cell transplantation. This study found that in patients
colonized with Candida, the presence of the Dectin-1
polymorphism reduced the incidence of acute GvHD.
Interestingly, recent studies have suggested a role for Th17
responses in the pathogenesis of GvHD (Carlson et al.
2009; Elmaagacli et al. 2008; Kappel et al. 2009). Con-
sidering that C. albicans is known to induce Th17
responses in mice and humans, the authors suggest that the
link between Candida colonization and acute GvHD may
be the induction of Th17 responses by the fungus (van der
Velden et al. 2010). Their results suggest that despite
increased colonization, defective Dectin-1 signaling pre-
vented an increase in Th17-mediated acute GvHD. This
study therefore established a link between Candida colo-
nization and acute GvHD in humans.
As discussed previously, CARD9 is a major component
of the downstream signaling pathway of Dectin-1, and
recently Glocker et al. (2009) described a mutation
causing a loss of function of CARD9 that was associated
with an increased susceptibility to chronic mucocutaneous
candidiasis. In addition, the CARD9
-/- patients had sig-
niﬁcantly reduced numbers of Th17 cells. This study
further supports the role of Dectin-1/Syk/CARD9 signal-
ing in the differentiation of Th17 cells and in antifungal
immunity.
Dectin-1 polymorphisms in other human diseases
The effects of Dectin-1 polymorphisms have also been
studied in other human diseases and are brieﬂy described
here. First, Dectin-1-mediated responses have been impli-
cated in driving autoimmunity. Fungal particles such as
zymosan and b-glucans can induce inﬂammation and
autoimmune arthritis in mice, and Yoshitomi et al. (2005)
have shown that blocking Dectin-1 prevented b-glucan-
induced autoimmune arthritis in genetically susceptible
mice. Therefore, in order to determine if Dectin-1 is
associated with rheumatoid arthritis (RA) in humans,
Plantinga et al. (2010) investigated clinical parameters of
inﬂammation and bone destruction in arthritis patients,
including those bearing the heterozygous Dectin-1 poly-
morphism. This study showed that partial Dectin-1 deﬁ-
ciency had no association with disease susceptibility or
with the degree of inﬂammation and bone destruction in
RA patients.
Mutations in CARD9 have been associated with
inﬂammatory bowel disease (IBD) (Zhernakova et al.
2008), and consequently the involvement of the Dectin-1
polymorphism in IBD was also investigated. Although
Dectin-1 expression was found to be elevated on macro-
phages, neutrophils, and other cells involved in the
inﬂammatory reaction in IBD lesions, the Dectin-1 poly-
morphism was found not to be a major susceptibility factor
for the development of this disease (de Vries et al. 2009).
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123Conclusion
The discovery of Dectin-1 has revolutionized our under-
standing of molecular mechanisms underlying innate rec-
ognition of fungi. The study of this receptor has revealed
novel insights into the intracellular signaling pathways and
cellular responses induced by fungal b-glucans. Deﬁnitive
evidence for its protective role in fungal disease has come
from studies of patients harboring a Dectin-1 polymor-
phism that results in defective expression of the protein.
Finally, given the current clinical evidence for the role of
this receptor in fungal diseases, looking at ways of
restoring the defective responses that are normally induced
by Dectin-1 may provide new avenues for therapeutic
intervention.
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